Essex Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.74M | Sell |
171,437
-1,229
| -0.7% | -$34K | 0.86% | 30 |
|
|
2025
Q1 | $3.83M | Sell |
172,666
-1,133
| -0.7% | -$25.2K | 0.8% | 37 |
|
|
2024
Q4 | $3.44M | Sell |
173,799
-26,717
| -13% | -$528K | 0.62% | 56 |
|
|
2024
Q3 | $5.01M | Buy |
200,516
+717
| +0.4% | +$17.9K | 0.87% | 33 |
|
|
2024
Q2 | $3.73M | Buy |
199,799
+27,059
| +16% | +$505K | 0.7% | 46 |
|
|
2024
Q1 | $3.41M | Buy |
172,740
+850
| +0.5% | +$16.8K | 0.67% | 49 |
|
|
2023
Q4 | $3.01M | Sell |
171,890
-13,963
| -8% | -$245K | 0.59% | 52 |
|
|
2023
Q3 | $3.23M | Sell |
185,853
-2,445
| -1% | -$42.5K | 0.53% | 59 |
|
|
2023
Q2 | $2.65M | Buy |
188,298
+69,128
| +58% | +$973K | 0.37% | 96 |
|
|
2023
Q1 | $1.28M | Buy |
+119,170
| New | +$1.28M | 0.19% | 167 |
|